Abstract: The present invention relates to a novel method for preparing a compound represented by formula 5 or a salt thereof set forth in the present specification, wherein the compound or salt can be used as a sphingosine-1-phosphate receptor agonist.
| # | Name | Date |
|---|---|---|
| 1 | 202317068667-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [12-10-2023(online)].pdf | 2023-10-12 |
| 2 | 202317068667-STATEMENT OF UNDERTAKING (FORM 3) [12-10-2023(online)].pdf | 2023-10-12 |
| 3 | 202317068667-REQUEST FOR EXAMINATION (FORM-18) [12-10-2023(online)].pdf | 2023-10-12 |
| 4 | 202317068667-PRIORITY DOCUMENTS [12-10-2023(online)].pdf | 2023-10-12 |
| 5 | 202317068667-POWER OF AUTHORITY [12-10-2023(online)].pdf | 2023-10-12 |
| 6 | 202317068667-FORM 18 [12-10-2023(online)].pdf | 2023-10-12 |
| 7 | 202317068667-FORM 1 [12-10-2023(online)].pdf | 2023-10-12 |
| 8 | 202317068667-DECLARATION OF INVENTORSHIP (FORM 5) [12-10-2023(online)].pdf | 2023-10-12 |
| 9 | 202317068667-COMPLETE SPECIFICATION [12-10-2023(online)].pdf | 2023-10-12 |
| 10 | 202317068667-MARKED COPIES OF AMENDEMENTS [16-11-2023(online)].pdf | 2023-11-16 |
| 11 | 202317068667-FORM 13 [16-11-2023(online)].pdf | 2023-11-16 |
| 12 | 202317068667-AMMENDED DOCUMENTS [16-11-2023(online)].pdf | 2023-11-16 |
| 13 | 202317068667-FORM 3 [08-03-2024(online)].pdf | 2024-03-08 |